Common Contracts
2 similar Securities Subscription Agreement contracts by HPX Corp., Ibere Pharmaceuticals
IBERE PHARMACEUTICALS Philadelphia, PA 19103Securities Subscription Agreement • February 9th, 2021 • Ibere Pharmaceuticals • Blank checks • New York
Ibere Pharmaceuticals, a Cayman Islands exempted company (the “Company”), is pleased to accept the offer PIPV Capital LLC, a Delaware limited liability company (the “Subscriber” or “you”), has made to subscribe for 2,875,000 of the Company’s Class B ordinary shares (the “Shares”), US $0.0001 par value per share (the “Class B Shares”), up to 375,000 of which are subject to forfeiture by you if the underwriters of the Company’s initial public offering of its securities (“IPO”), if any, do not fully exercise their overallotment option (the “Overallotment Option”). For the purposes of this agreement (this “Agreement”), references to “Ordinary Shares” are to, collectively, the Class B Shares and the Company’s Class A ordinary shares, US $0.0001 par value per share (the “Class A Shares”). Upon certain terms and conditions, the Class B Shares will automatically convert into Class A Shares on a one-for-one basis, subject to adjustment. Unless the context otherwise requires, as used herein “Sha
HPX CORP. Wilmington, Delaware, 19801Securities Subscription Agreement • June 26th, 2020 • HPX Corp. • Blank checks • New York
HPX Corp., a Cayman Islands exempted company (the “Company”), is pleased to accept the offer HPX Capital Partners LLC, a Delaware limited liability company (the “Subscriber” or “you”), has made to subscribe for 5,750,000 of the Company’s Class B ordinary shares (the “Shares”), US$0.0001 par value per share (the “Class B Shares”), up to 750,000 of which are subject to forfeiture by you if the underwriters of the Company’s initial public offering of its securities (“IPO”), if any, do not fully exercise their over-allotment option (the “Over-allotment Option”). For the purposes of this agreement (this “Agreement”), references to “Ordinary Shares” are to, collectively, the Class B Shares and the Company’s Class A ordinary shares, US$0.0001 par value per share (the “Class A Shares”). Upon certain terms and conditions, the Class B Shares will automatically convert into Class A Shares on a one-for-one basis, subject to adjustment. Unless the context otherwise requires, as used herein “Shares”
